ContraFect (STU:22R) E10: €-5,973.20 (As of Sep. 2023)


STU:22R ContraFect Corp STU:22R
28 GF Score
Price €4.98
View Full Analysis

What is ContraFect E10?

ContraFect STU:22R 28 E10 is €-5,973.20 as of Sep. 2023. GuruFocus rates STU:22R with a GF Score™ of 28/100.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

ContraFect's adjusted earnings per share data for the three months ended in Sep. 2023 was €-0.469. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-5,973.20 for the trailing ten years ended in Sep. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-07-09), ContraFect's current stock price is €4.984. ContraFect's E10 for the quarter that ended in Sep. 2023 was €-5,973.20. ContraFect's Shiller PE Ratio of today is .


ContraFect  (STU:22R) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


ContraFect E10 Related Terms


ContraFect E10 Historical Data

* Premium members only.

The historical data trend for ContraFect's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ContraFect E10 Chart

ContraFect Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -664.09

ContraFect Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -764.97 -664.09 -2,042.57 -2,392.12 -5,973.20

STU:22R vs ADTX, RUBY, NBY: E10 Comparison

For the Biotechnology subindustry, ContraFect's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ContraFect Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ContraFect's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where ContraFect's Shiller PE Ratio falls into.


STU:22R
28GF Score
ContraFect Corp STU:22R
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ContraFect E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, ContraFect's adjusted earnings per share data for the three months ended in Sep. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=-0.469/307.7890*307.7890
=-0.469

Current CPI (Sep. 2023) = 307.7890.

ContraFect Quarterly Data

per share eps CPI Adj_EPS
201312 -596.582 233.049 -787.909
201403 -281.763 236.293 -367.017
201406 -252.311 238.343 -325.827
201409 -757.376 238.031 -979.335
201412 -152.010 234.812 -199.253
201503 -177.408 236.119 -231.257
201506 -235.224 238.638 -303.386
201509 -156.816 237.945 -202.846
201512 -205.632 236.525 -267.588
201603 -229.888 238.132 -297.134
201606 -249.200 241.018 -318.238
201609 -199.584 241.428 -254.443
201612 68.256 241.432 87.016
201703 -112.200 243.801 -141.648
201706 -49.840 244.955 -62.625
201709 -13.424 246.819 -16.740
201712 -40.560 246.524 -50.640
201803 -168.688 249.554 -208.052
201806 -184.896 251.989 -225.839
201809 -41.136 252.439 -50.156
201812 49.224 251.233 60.305
201903 103.368 254.202 125.158
201906 -77.172 256.143 -92.732
201909 -48.669 256.759 -58.342
201912 -79.920 256.974 -95.724
202003 -35.476 258.115 -42.303
202006 -62.515 257.797 -74.638
202009 -12.905 260.280 -15.261
202012 -15.125 260.474 -17.872
202103 -12.096 264.877 -14.056
202106 -9.296 271.696 -10.531
202109 -8.840 274.310 -9.919
202112 -7.788 278.802 -8.598
202203 -37.228 287.504 -39.855
202206 -34.803 296.311 -36.151
202209 -35.067 296.808 -36.364
202212 -15.236 296.797 -15.800
202303 -0.644 301.836 -0.657
202306 -1.791 305.109 -1.807
202309 -0.469 307.789 -0.469

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €-5,973.20 mean?
ContraFect (STU:22R) has a E10 of €-5,973.20 as of Sep. 2023. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on ContraFect and its competitors.
Is ContraFect's E10 too high?
ContraFect's current E10 is €-5,973.20. Overall, ContraFect has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does ContraFect's E10 compare to ADTX and RUBY?
ContraFect's E10 of €-5,973.20 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on ContraFect and its competitors. ContraFect's current E10 is €-5,973.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ContraFect stock overvalued right now?
ContraFect (STU:22R) has a current E10 of €-5,973.20. The current E10 is €-5,973.20. ContraFect's overall GF Score™ is 28/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For ContraFect (STU:22R), the current E10 is €-5,973.20 as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ContraFect Business Description

Address 28 Wells Avenue, 3rd Floor, Yonkers, NY, USA, 10701
ContraFect Corp is a late clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections. Its DLA product candidate, exebacase, is currently being studied in patients with chronic prosthetic joint infections (PJIs) of the knee due to S. aureus or coagulase-negative Staphylococci, and the next product candidate, CF-370, is designed to target a range of gram-negative bacteria, including P. aeruginosa, K. pneumoniae, and A. baumannii, and has demonstrated potent in vivo activity against these pathogens, even against multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains.
28GF Score

Get the complete analysis for STU:22R

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.98
Price